THE PARTICIPATION OF HUMORAL MECHANISMS IN THE REGULATION OF THE CONTRACTILE ACTIVITY OF SMOOTH MUSCLE TISSUE OF THE INTESTINE

Oliinyk T. M., Rozova K. V., Kovalchuk O. I., Raskaliei T. Ya., Raskaliei V. B., Khmelnytska Yu. K.

THE PARTICIPATION OF HUMORAL MECHANISMS IN THE REGULATION OF THE CONTRACTILE ACTIVITY OF SMOOTH MUSCLE TISSUE OF THE INTESTINE


Show/Download

About the author:

Oliinyk T. M., Rozova K. V., Kovalchuk O. I., Raskaliei T. Ya., Raskaliei V. B., Khmelnytska Yu. K.

Heading:

LITERATURE REVIEWS

Type of article:

Scientific article

Annotation:

The large intestine is the most distal part of the alimentary canal, the main function of which is to prepare undigested food residues for removal from the body and evacuate them to the outside. This is ensured by the implementation of the contractile function of the smooth muscle tissue of the intestinal wall, which is characterized by rhythmic phasic, tonic and high-amplitude propulsive contractions. The amplitude and frequency of these contractions are determined by the complex interaction of complex nervous, humoral and myogenic regulation mechanisms. Nervous effects on smooth muscle tissue are realized due to the implementation of metasympathetic enteric motor reflexes and innervation of extra-organ nerves. They add up with numerous and complex humoral effects. The stimulating effect on the motor function of the intestine is determined by the influence of purines and some regulatory peptides, and serotonergic and tachykininergic effects play a modulating role in this complex regulatory process. The final point of application of humoral effector effects is the secretion of acetylcholine by cholinergic excitatory motoneurons and the release of nitric oxide and vasoactive intestinal peptide. It is worth noting that, in addition to the above, a number of other endogenous biologically active substances (short-chain fatty acids, neurotrophic factors, sex hormones, histamine, prostaglandins, etc.) take part in the modulation of the contractile activity of the smooth muscle tissue of the colon. However, the deep nature of the mechanisms that exert regulatory effects on the contractile activity of the smooth muscles of the colon wall is still not sufficiently understood.

Tags:

contractile activity, motor function, regulation, smooth muscle tissue

Bibliography:

  1. Tack J, Janssen P. Gastroduodenal motility. Curr Opin Gastroenterol. 2010 Nov;26(6):647-55. DOI: 10.1097/MOG.0b013e32833ece1e.
  2. Corsetti M, Costa M, Bassotti G, Bharucha AE, Borrelli O, Dinning P, et al. First translational consensus on terminology and definitions of colonic motility in animals and humans studied by manometric and other techniques. Nat Rev Gastroenterol Hepatol. 2019 Sep;16(9):559- 579. DOI: 10.1038/s41575-019-0167-1.
  3. Dinning PG. A new understanding of the physiology and pathophysiology of colonic motility? Neurogastroenterol Motil. 2018 Nov;30(11):e13395. DOI: 10.1111/nmo.13395.
  4. Heitmann PT, Vollebregt PF, Knowles CH, Lunniss PJ, Dinning PG, Scott SM. Understanding the physiology of human defaecation and disorders of continence and evacuation. Nat Rev Gastroenterol Hepatol. 2021 Nov;18(11):751-769. DOI: 10.1038/s41575-021-00487-5.
  5. Kornum DS, Terkelsen AJ, Bertoli D, Klinge MW, Hoyer KL, Kufaishi HA, et al. Assessment of Gastrointestinal Autonomic Dysfunction: Present and Future Perspectives. J Clin Med. 2021 Mar 31;10(7):1392. DOI: 10.3390/jcm10071392.
  6. Bharucha AE, Lacy BE. Mechanisms, Evaluation, and Management of Chronic Constipation. Gastroenterology. 2020 Apr;158(5):1232- 1249.e3. DOI: 10.1053/j.gastro.2019.12.034.
  7. Nehra AK, Sheedy SP, Johnson CD, Flicek KT, Venkatesh SK, Heiken JP, et al. Imaging Review of Gastrointestinal Motility Disorders. Radiographics. 2022 Nov-Dec;42(7):2014-2036. DOI: 10.1148/rg.220052.
  8. Becher KF, Rupp S. Intestinal motility disorders in multimorbidity: between constipation and diarrhea. Dtsch Med Wochenschr. 2020 Oct;145(20):1456-1459. DOI: 10.1055/a-1165-1351.
  9. Wang Q, Wang K, Solorzano-Vargas RS, Lin P, Walthers CM, Thomas AL, et al. Bioengineered intestinal muscularis complexes with longterm spontaneous and periodic contractions. PLoS One. 2018 May 2;13(5):e0195315. DOI: 10.1371/journal.pone.0195315.
  10. Fung C, Berghe PV. Functional circuits and signal processing in the enteric nervous system. Cell Mol Life Sci. 2020 Nov;77(22):4505-4522. DOI: 10.1007/s00018-020-03543-6.
  11. Kobayashi M, Khalil HA, Lei NY, Wang Q, Wang K, Wu BM, et al. Bioengineering functional smooth muscle with spontaneous rhythmic contraction in vitro. Sci Rep. 2018 Sep 10;8(1):13544. DOI: 10.1038/s41598-018-31992-4.
  12. Lies B, Beck K, Keppler J, Saur D, Groneberg D. Nitrergic signalling via interstitial cells of Cajal regulates motor activity in murine colon. J Physiol. 2015 Oct 15;593(20):4589-601. DOI: 10.1113/JP270511.
  13. Beck K, Friebe A, Voussen B. Nitrergic signaling via interstitial cells of Cajal and smooth muscle cells influences circular smooth muscle contractility in murine colon. Neurogastroenterol Motil. 2018 Jun;30(6):e13300. DOI: 10.1111/nmo.13300.
  14. Sanders KM, Kito Y, Hwang SJ, Ward SM. Regulation of Gastrointestinal Smooth Muscle Function by Interstitial Cells. Physiology (Bethesda). 2016 Sep;31(5):316-26. DOI: 10.1152/physiol.00006.2016.
  15. Sharkey KA, Mawe GM. The enteric nervous system. Physiol Rev. 2023 Apr 1;103(2):1487-1564. DOI: 10.1152/physrev.00018.2022.
  16. Schneider S, Wright CM, Heuckeroth RO. Unexpected Roles for the Second Brain: Enteric Nervous System as Master Regulator of Bowel Function. Annu Rev Physiol. 2019 Feb 10;81:235-259. DOI: 10.1146/annurev-physiol-021317-121515.
  17. Spencer NJ, Hu H. Enteric nervous system: sensory transduction, neural circuits and gastrointestinal motility. Nat Rev Gastroenterol Hepatol. 2020 Jun;17(6):338-351. DOI: 10.1038/s41575-020-0271-2.
  18. Kitazawa T, Kaiya H. Motilin Comparative Study: Structure, Distribution, Receptors, and Gastrointestinal Motility. Front Endocrinol (Lausanne). 2021 Aug 23;12:700884. DOI: 10.3389/fendo.2021.700884.
  19. Kitazawa T, Kaiya H. Regulation of Gastrointestinal Motility by Motilin and Ghrelin in Vertebrates. Front Endocrinol (Lausanne). 2019 May 17;10:278. DOI: 10.3389/fendo.2019.00278.
  20. Kendig DM, Grider JR. Serotonin and colonic motility. Neurogastroenterol Motil. 2015 Jul;27(7):899-905. DOI: 10.1111/nmo.12617.
  21. Yu Y, Chen JH, Li H, Yang Z, Du X, Hong L, et al. Involvement of 5-HT3 and 5-HT4 receptors in colonic motor patterns in rats. Neurogastroenterol Motil. 2015 Jul;27(7):914-28. DOI: 10.1111/nmo.12550.
  22. Kim HS. 5-Hydroxytryptamine4 receptor agonists and colonic motility. J Smooth Muscle Res. 2009 Feb;45(1):25-9. DOI: 10.1540/ jsmr.45.25.
  23. Mawe GM, Hoffman JM. Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2013 Aug;10(8):473-86. DOI: 10.1038/nrgastro.2013.105.
  24. Nilsson S. Comparative anatomy of the autonomic nervous system. Aut Neurosci Basic Clin. 2011;165(1):3-9.
  25. Hammerle CW, Surawicz CM. Updates on treatment of irritable bowel syndrome. World J Gastroenterol. 2008;141(7):2639-49.
  26. Keating DJ, Spencer NJ. What is the role of endogenous gut serotonin in the control of gastrointestinal motility? Pharmacol Res. 2019 Feb;140:50-55. DOI: 10.1016/j.phrs.2018.06.017.
  27. Johnson DE, Drummond E, Grimwood S, Sawant-Basak A, Miller E, Tseng E, et al. The 5-hydroxytryptamine 4 receptor agonists prucalopride and PRX-03140 increase acetyl-choline and histamine levels in the rat prefron-tal cortex and the power of stimulated hippocampal в oscillations. J Pharmacol Exp. 2012;341(3):681-91.
  28. Li CY, Li SC. Treatment of irritable bowel syndrome in China: a review. World J Gastroenterol. 2015;21(8):2315-22. DOI: 10.3748/wjg.v21. i8.2315.
  29. Najjar SA, Hung LY, Margolis KG. Serotonergic Control of Gastrointestinal Development, Motility, and Inflammation. Compr Physiol. 2023 Jun 26;13(3):4851-4868. DOI: 10.1002/cphy.c220024.
  30. Annaházi A, Berger TE, Demir IE, Zeller F, Müller M, Anneser M, et al. Metabotropic 5-HT receptor-mediated effects in human submucous plexus. Neurogastroenterol Motil. 2022;34:e14380. DOI: 10.1111/nmo.14380.
  31. Borman RA, Tilford NS, Harmer DW. 5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro. Br J Pharmacol. 2002;135(5):1144-1151.
  32. Watson J, Roberts C, Scott C, Kendall I, Collin L, Day NC, et al. SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue. Br J Pharmacol. 2001;133(6):797-806. DOI: 10.1038/sj.bjp.070 4133.
  33. Mikami T, Sugimoto H, Naganeo R, Ohmi T, Saito T, Eda H. Contribution of active and inactive states of the human 5-HT4d receptor to the functional activities of 5-HT4-receptor agonists. J Pharmacol Sci. 2008 Jul;107(3):251-9. DOI: 10.1254/jphs.fp0072230.
  34. De Maeyer JH, Lebebvre RA, Schuurkes JA. 5-HT4 receptor agonists: similar but not the same. Neurogastroenterol Motil. 2008;20:99-112.
  35. Cash BD, Chey WD. The role of serotonergic agents in the treatment of patients with primary chronic constipation. Aliment Pharmacol Ther. 2005;22(11-12):1047-60.
  36. Beattie DT, Smith JAM. Serotonin pharmacology in the gastrointestinal tract: a review. Naunyn Schmiedebergs Arch Pharmacol. 2008 May;377(3):181-203. DOI: 10.1007/s00210-008-0276-9.
  37. Cellek S, Thangiah R, Jarvie EM. Synergy between 5-HT4 receptor activation and acetylcholinesterase inhibition in human colon and rat forestomach. Neurogastroenterol Motil. 2008;20(5):539-545.
  38. Sanger GJ. Translating 5-HT receptor pharmacology. Neurogastroenterol Motil. 2009 Dec;21(12):1235-8. DOI: 10.1111/j.1365- 2982.2009.01425.x.
  39. Guzel T, Mirowska-Guzel D. The Role of Serotonin Neurotransmission in Gastrointestinal Tract and Pharmacotherapy. Molecules. 2022 Mar 3;27(5):1680. DOI: 10.3390/molecules27051680.
  40. Swami T, Weber HC. Updates on the biology of serotonin and tryptophan hydroxylase. Curr Opin Endocrinol Diabetes Obes. 2018 Feb;25(1):12-21. DOI: 10.1097/MED.0000000000000383.
  41. Stasi C, Sadalla S, Milani S. The Relationship Between the Serotonin Metabolism, Gut-Microbiota and the Gut-Brain Axis. Curr Drug Metab. 2019;20(8):646-655. DOI: 10.2174/1389200220666190725115503.
  42. Chevalier NR, Dacher N, Jacques C, Langlois L, Guedj C, Faklaris O. Embryogenesis of the peristaltic reflex. J Physiol. 2019 May;597(10):2785-2801. DOI: 10.1113/JP277746.
  43. Zhang Y, Paterson WG. Characterization of the peristaltic reflex in murine distal colon. Can J Physiol Pharmacol. 2016 Feb;94(2):190-198. DOI: 10.1139/cjpp-2015-0086.
  44. De Ponti F. Pharmacology of serotonin: what a clinician should know. Gut. 2004;53:1520-35.
  45. Priem EK, De Maeyer JH, Vandewoestyne M. Predominant mucosal expression of 5-HT4 (+h) receptor splice variants in pig stomach and colon. World J. Gastroenterol. 2013;19(24):3747-60.
  46. Tzavella K, Riepl R, Klauser A. Decreased substance P levels in rectal biopsies from patients with slow transit constipation. Eur. J. Gastroenterol. Hepatol. 1996;8(12):1207-11.
  47. Holzer P, Petsche U. Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation. Pharmacol Ther. 1997;73(3):219- 63. DOI: 10.1016/s0163-7258(96)00196-9.
  48. Mazzoni M, Cabanillas L, Costanzini A, Caremoli F, Million M, Larauche M, et al. Distribution, quantification, and characterization of substance P enteric neurons in the submucosal and myenteric plexuses of the porcine colon. Cell Tissue Res. 2023 Nov 20. DOI: 10.1007/ s00441-023-03842-x.
  49. Yan Y, Ramanan D, Rozenberg M, McGovern K, Rastelli D, Vijaykumar B, et al. Interleukin-6 produced by enteric neurons regulates the number and phenotype of microbe-responsive regulatory T cells in the gut. Immunity. 2021 Mar 9;54(3):499-513. DOI: 10.1016/j. immuni.2021.02.002.
  50. Spencer NJ, Kyloh MA, Travis L, Dodds KN. Identification of spinal afferent nerve endings in the colonic mucosa and submucosa that communicate directly with the spinal cord: The gut-brain axis. J Comp Neurol. 2020 Jul;528(10):1742-1753. DOI: 10.1002/cne.24854.
  51. Gaumnitz E, Sweet MA, Sengupta A, Singaram C. Nitrinergic and peptiderg
  52. Sanders KM, Keef KD. Cellular mediators of nitrergic neurotransmission in GI smooth muscles: no easy answer. J Physiol. 2015 Oct 15;593(20):4511-2. DOI: 10.1113/JP271320.
  53. Sang Q, Young HM. Chemical coding of neurons in the myenteric plexus and external muscle of the small and large intestine of the mouse. Cell Tissue Res. 1996;284(1):39-53.
  54. Krowicki ZK, Sharkey KA, Serron SC. Distribution of nitric oxide synthase in rat dorsal vagal complex and eff ects of microinjection of nitric oxide compounds upon gastric motor function. J. ComP. Neurol. 1997;377(1):49-69.
  55. Shuttleworth CW, Weinert JS, Sanders KM, Buxton IL. Detection of nitric oxide release from canine enteric neurons. J. Auton. Nerv. Syst. 1995;56(1):61-8.
  56. Konturek PC, Kania J, Hahn EG, Konturek JW. Ascorbic acid attenuates aspirin-induced gastric damage: role of inducible nitric oxide synthase. J. Physiol. Pharmacol. 2006;57(5):125-36.
  57. Cherbut C. Motor effects of short-chain fatty acids and lactate in the gastrointestinal tract. Proc Nutr Soc. 2003 Feb;62(1):95-9. DOI: 10.1079/PNS2002213.
  58. Shaidullov IF, Sorokina DM, Sitdikov FG, Hermann A, Abdulkhakov SR, Sitdikova GF. Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome. BMC Gastroenterol. 2021 Jan 26;21(1):37. DOI: 10.1186/s12876-021-01613-y.
  59. Jiang W, Wu J, Zhu S, Xin L, Yu C, Shen Z. The Role of Short Chain Fatty Acids in Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2022 Oct 30;28(4):540-548. DOI: 10.5056/jnm22093.
  60. Natale G, Ryskalin L, Busceti CL, Biagioni F, Fornai F. The nature of catecholamine-containing neurons in the enteric nervous system in relationship with organogenesis, normal human anatomy and neurodegeneration. Arch Ital Biol. 2017 Sep 1;155(3):118-130. DOI: 10.12871/00039829201733.
  61. Ohlsson B., Ringstrom G., Abrahamsson H., Simren M., Bjornsson ES. Oxytocin stimulates colonic motor activity in healthy women. Neurogastroenterol Motil. 2004 Apr;16(2):233-40. DOI: 10.1111/j.1365-2982.2004.00507.x.

Publication of the article:

«Bulletin of problems biology and medicine», 2023 Issue 4, 171, 42-47 pages, index UDC 612.36+616.008.3/5«312»

DOI:

10.29254/2077-4214-2023-4-171-42-47

Was this article helpful?

Leave a Reply

Your email address will not be published. Required fields are marked *


The reCAPTCHA verification period has expired. Please reload the page.